Triple-Encoding Platform for Multiplexed In Situ Profiling of Extracellular Vesicle miRNAs Enables Precision Diagnosis of Ovarian Cancer
ACS Nano · 2026
DOI: 10.1021/acsnano.6c12452 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Haimeng Pei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang310022, P. R. China. Hauptthemen laut MEDLINE: MicroRNAs, Ovarian Neoplasms, Extracellular Vesicles, Gene Expression Profiling. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, Health Commission of Zhejiang Province, Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang Province.
Abstract (Originalsprache)
Ovarian cancer, the most lethal gynecologic malignancy, urgently demands early and accurate diagnostic methods. Tumor-derived extracellular vesicles (tEVs) hold great promise as noninvasive biomarkers, yet their clinical translation is severely hampered by inherent heterogeneity and the inability of conventional assays to detect multiple types of biomarkers. To break this bottleneck, we developed a novel one-pot, triple-encoding platform that integrates size–fluorescence-encoded beads with a membrane fusion strategy. This enables simultaneous in situ profiling of 11 miRNAs across three distinct EV subpopulations defined by EpCAM/PD-L1 expression. Leveraging machine learning, an 11-miRNA logistic panel achieved tumor versus health discrimination (AUC = 0.995), and a combinatorial signature based on EV subpopulations and miRNA profiles enabled the classification of ovarian cancer subtypes, achieving 78.6% accuracy in the validation cohort. Our work provides a versatile and scalable approach for multiparameter EV analysis, enabling comprehensive EV miRNA profiling and ovarian cancer classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang310022, P. R. China.
- Department of Clinical Laboratory, The Second Qilu Hospital of Shandong University, Jinan, Shandong250012, P. R. China.
- School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang310024, P. R. China.
Förderung
- Key Research and Development Program of Zhejiang Province
- Health Commission of Zhejiang Province
- Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang Province
- Hangzhou Institute of Medicine, CAS
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Pei, H., Kuang, T., Dai, Y., Li, J., Zheng, L., Tan, Q., & Qu, F. (2026). Triple-Encoding Platform for Multiplexed In Situ Profiling of Extracellular Vesicle miRNAs Enables Precision Diagnosis of Ovarian Cancer. ACS Nano. https://doi.org/10.1021/acsnano.6c12452
Vancouver
Pei H, Kuang T, Dai Y, Li J, Zheng L, Tan Q, et al. Triple-Encoding Platform for Multiplexed In Situ Profiling of Extracellular Vesicle miRNAs Enables Precision Diagnosis of Ovarian Cancer. ACS Nano. 2026. doi:10.1021/acsnano.6c12452
BibTeX
@article{Pei2026,
author = {Pei, Haimeng and Kuang, Tingzhi and Dai, Yuting and Li, Jin and Zheng, Liyan and Tan, Qingqing and Qu, Fengli},
title = {Triple-Encoding Platform for Multiplexed In Situ Profiling of Extracellular Vesicle miRNAs Enables Precision Diagnosis of Ovarian Cancer},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c12452}
}
EUVIMED